Oncotarget is a peer-reviewed publication. It is published every week. In it a reader will find the latest discoveries resulting from numerous scientific research on oncology and various other medical-related topics. Its parent is Impact Journals.
The Oncotarget put out its premiere article approximately seven years ago. The Oncotarget has since grown to become a source of publication for literally thousands of peer-reviewed articles. The articles are reported to be generally insightful and are all published in the international language of English and more information click here.
This decision was made by management in order to ensure that a significantly sizeable part of the planet’s population could read all of the articles. The Oncotarget is officially classified as an “open-access journal.” This basically means that any research scientist or research group involved in scientific research has, in theory, the chance to use this research journal.
The Oncotarget Team
Internet sources indicate that Oncotarget’s founders are dedicated, talented, and qualified. They are also reported to have a significant reputation for their research as well. Oncotarget is headed up by the two chief editors professor Mikhail Blagoskloklonny and professor Andre V. Gudkov and learn more about Oncotarget.
Oncotarget’s Chief Editors
Oncotarget’s pair of chief editors are respected, popular professors at the Roswell Park Cancer Institute found in Buffalo, New York. Gudkov has actually made noteworthy contributions in the field of cancer therapy and treatment, especially when it comes to molecular targets and the discovery of medications. Blagosklonny himself wrote over 250 scientific articles in several peer-reviewed journals.
Submissions And Statistics
The publication’s staff ensures that each submission that is accepted for publication meets a set of high standards concerning qualitative and educational value. In its first year of publication, Oncotarget had an impact factor (IF) of 4.78 and was seen by readers in 493 cities and Oncotarget’s lacrosse camp.
In 2013 Oncotarget was actually registered as receiving the “highest impact factor” of 6.727. Furthermore, it increased its overall circulation to over 30,000 cities. The general reception of the Oncotarget has now multiplied by nearly 100 times since its launch and https://oncotarget.msubmit.net/cgi-bin/main.plex.
A report issued by the Centre for Diseases Control as well as Prevention indicates that approximately 2.6 million individuals lose their lives to misdiagnosed diseases in the United States of America. Approximately seven out of possibly ten deaths are caused by chronic diseases that could have been prevented through early diagnosis. Although death, as well as disease, cannot be avoided, there is a preventive platform for life threatening diseases given the modern treatment channels. That comes with taking care of an individual’s health through proper management. Towards this end, Life Line Screening has been receiving positive reviews concerning its input to offering preventive measures when it comes to providing early diagnosis and read full article.
Life Line Screening was established with the understanding that everyone is different. There is also a clear knowledge of a particular set of risk factors that can affect health. Although every individual can benefit from the health screening, some tests are more vital compared to others. This is because such tests offer more insight on the progress of the disease. Life Line Screening is objective towards identifying tests that are more crucial as well as beneficial to the health of the patient. These tests are conducted based on the age of the patient, medical history, overall health as well as the family history of the patient. The comprehensive program of Life Line Screening offers a variety of tests and Life Line Screening on Facebook.
Life Line Screening was established in 1993. The founders are Colin Scully as well as Timothy Philips. Since then, the company has extended its operations across the United States of America as well as the United Kingdom. In 1998, Life Line Screening had extended its screening services across the United States of America by covering over 500,000 individuals. Life Line Screening offers blood tests through the screening services. It also provides a broad range of complete cholesterol checkups, diabetes as well as inflammation. Under the leadership of Andrew Manganaro, Life Line Screening has catered for more than 1 million patients every year. Some of the diseases that can be detected by Life Line Screening include peripheral arterial disease, abdominal as well as atrial fibrillation and learn more about Life Line Screening.
More Visit: http://www.naifa.org/practice-resources/prp/lifeline-screening